» Articles » PMID: 28083883

A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy

Overview
Date 2017 Jan 14
PMID 28083883
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

This preclinical study examines light fluence, photodynamic therapy (PDT) dose and "apparent reacted singlet oxygen," [ O ] , to predict local control rate (LCR) for Photofrin-mediated PDT of radiation-induced fibrosarcoma (RIF) tumors. Mice bearing RIF tumors were treated with in-air fluences (50-250 J cm ) and in-air fluence rates (50-150 mW cm ) at Photofrin dosages of 5 and 15 mg kg and a drug-light interval of 24 h using a 630-nm, 1-cm-diameter collimated laser. A macroscopic model was used to calculate [ O ] and PDT dose based on in vivo explicit dosimetry of the drug concentration, light fluence and tissue optical properties. PDT dose and [ O ] were defined as a temporal integral of drug concentration and fluence rate, and singlet oxygen concentration consumed divided by the singlet oxygen lifetime, respectively. LCR was stratified for different dose metrics for 74 mice (66 + 8 control). Complete tumor control at 14 days was observed for [ O ] ≥ 1.1 mm or PDT dose ≥1200 μm J cm but cannot be predicted with fluence alone. LCR increases with increasing [ O ] and PDT dose but is not well correlated with fluence. Comparing dosimetric quantities, [ O ] outperformed both PDT dose and fluence in predicting tumor response and correlating with LCR.

Citing Articles

A Review of the Efficacy of Nanomaterial-Based Natural Photosensitizers to Overcome Multidrug Resistance in Cancer.

Rajaram J, Mende L, Kuthati Y Pharmaceutics. 2024; 16(9).

PMID: 39339158 PMC: 11434998. DOI: 10.3390/pharmaceutics16091120.


Clinical PDT dose dosimetry for pleural Photofrin-mediated photodynamic therapy.

Sun H, Ong Y, Yang W, Sourvanos D, Dimofte A, Busch T J Biomed Opt. 2024; 29(1):018001.

PMID: 38223299 PMC: 10787190. DOI: 10.1117/1.JBO.29.1.018001.


An Analysis of the Effects of In Vitro Photodynamic Therapy on Prostate Cancer Tissue by Histopathological Examination and Magnetic Resonance Imaging.

Aebisher D, Osuchowski M, Bartusik-Aebisher D, Krupka-Olek M, Dynarowicz K, Kawczyk-Krupka A Int J Mol Sci. 2022; 23(19).

PMID: 36232657 PMC: 9570148. DOI: 10.3390/ijms231911354.


Real-time PDT Dose Dosimetry for Pleural Photodynamic Therapy.

Zhu T, Sun H, Ong Y, Morales R, Dimofte A, Busch T Proc SPIE Int Soc Opt Eng. 2022; 11940.

PMID: 35573026 PMC: 9104001. DOI: 10.1117/12.2612188.


Effects of patient-specific treatment planning on eligibility for photodynamic therapy of deep tissue abscess cavities: retrospective Monte Carlo simulation study.

Li Z, Nguyen L, Bass D, Baran T J Biomed Opt. 2022; 27(8).

PMID: 35146973 PMC: 8831513. DOI: 10.1117/1.JBO.27.8.083007.


References
1.
Zhou X, Pogue B, Chen B, Demidenko E, Joshi R, Hoopes J . Pretreatment photosensitizer dosimetry reduces variation in tumor response. Int J Radiat Oncol Biol Phys. 2006; 64(4):1211-20. DOI: 10.1016/j.ijrobp.2005.11.019. View

2.
Wang K, Mitra S, Foster T . A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy. Med Phys. 2007; 34(1):282-93. DOI: 10.1118/1.2401041. View

3.
Hu X, Feng Y, Lu J, Allison R, Cuenca R, Downie G . Modeling of a type II photofrin-mediated photodynamic therapy process in a heterogeneous tissue phantom. Photochem Photobiol. 2005; 81(6):1460-8. DOI: 10.1562/2005-05-04-RA-513. View

4.
Dolmans D, Fukumura D, Jain R . Photodynamic therapy for cancer. Nat Rev Cancer. 2003; 3(5):380-7. DOI: 10.1038/nrc1071. View

5.
Whiteley J, Gavaghan D, Hahn C . Mathematical modelling of oxygen transport to tissue. J Math Biol. 2002; 44(6):503-22. DOI: 10.1007/s002850200135. View